Health News

FDA Approves Xarelto To Reduce Risk Of Blood Clots
On July 1, the U.S. Food and Drug Administration approved Xarelto ( rivaroxaban ) to reduce the risk of blood clots, deep vein thrombosis ( DVT ), and pulmonary embolism (PE) following knee or hip replacement surgery.
Minimizing Adverse Reactions by Stopping the Bleeding
Patients with acute coronary syndromes often must resort to stents or balloon angioplasty to relieve artery constriction. Now the European Society of Cardiology is suggesting new strategies to minimize bleeding during such procedures.
Patients Receive Blood Vessels Made From Donor Cells
Three patients with end stage renal disease mark the first to successfully receive blood vessels engineered in a lab from human skin cells. Following additional testing, "off the shelf" blood vessels could be as readily available as medical gauze.
Hospital Eliminates Type of Bloodstream Infection
Bloodstream infections are an ongoing concern in all hospital intensive care units. One large academic medical facility has found a way to eliminate a type of bloodstream infection over the last six months.
Common Pain Reliever Linked to Cancer
Millions of people use over-the-counter pain relievers known as analgesics and nonsteroidal anti-inflammatory drugs (NSAIDs) every day. A new study shows that using a certain one of these medicines on a regular basis carries risks.
New Drug Therapy Shows Promise in Treating Leukemia
Acute lymphoblastic leukemia is the most common type of childhood cancer. A new drug therapy holds promise in treating this particularly aggressive disease.
Preventing Children's Cancers From Returning
Acute lymphoblastic leukemia (ALL) used to be one of the deadliest cancers for children and young adults. Now it's one of the most curable, and cures rates are climbing.
Understanding of Alzheimer's Expanding
If we only knew exactly what caused Alzheimer's disease, it might be easier to treat. Scientists are making headway in both arenas. 
New Hope for Multiple Myeloma Patients
While there is no cure for multiple myeloma, a form of blood cancer, new therapy offers hope for keeping the disease from progressing. When used as a maintenance or ongoing therapy, Revlimid (lenalidomide) delays the progression of multiple myeloma and improves overall survival of newly diagnosed patients who have had a stem-cell transplant.
Dental Pain Reliever May Be Dangerous
The FDA continues to receive reports about a life-threatening side effect of a dental pain reliever called benzocaine .